cetylpyridinium chloride anhydrous has been researched along with eptifibatide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, TF; Deng, CY; Huang, XZ; Kuang, SJ; Li, XH; Lin, QX; Lin, SG; Mai, LP; Shan, ZX; Yang, M; Yu, XY; Zhou, ZL; Zhu, P | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and eptifibatide
Article | Year |
---|---|
Improved liquid chromatography-tandem mass spectrometry method for the analysis of eptifibatide in human plasma.
Topics: Asian People; Chromatography, Liquid; Drug Stability; Eptifibatide; Female; Health; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors | 2010 |